Creating Matched In vivo/In vitro Patient-Derived Model Pairs of PDX and PDX-Derived Organoids for Cancer Pharmacology Research
May 5th, 2021
•A method is described to create organoids using patient-derived xenografts (PDX) for in vitro screening, resulting in matched pairs of in vivo/in vitro models. PDX tumors were harvested/processed into small pieces mechanically or enzymatically, followed by the Clevers’ method to grow tumor organoids that were passaged, cryopreserved and characterized against the original PDX.
Tags
Related Videos
A Melanoma Patient-Derived Xenograft Model
Establishment of Gastric Cancer Patient-derived Xenograft Models and Primary Cell Lines
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
High-Throughput In Vitro Assay using Patient-Derived Tumor Organoids
Profiling Sensitivity to Targeted Therapies in EGFR-Mutant NSCLC Patient-Derived Organoids
Generation and Culturing of High-Grade Serous Ovarian Cancer Patient-Derived Organoids
Establishment and Culture of Patient-Derived Breast Organoids
Visualizing DNA Damage Repair Proteins in Patient-Derived Ovarian Cancer Organoids via Immunofluorescence Assays
Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
Ovarian Cancer Patient-Derived Organoid Models for Pre-Clinical Drug Testing
